INTERNATIONAL PATENT: CORCEPT THERAPEUTICS INCORPORATED FILES APPLICATION FOR "CONCOMITANT ADMINISTRATION OF SELECTIVE GLUCOCORTICOID RECEPTOR MODULATOR RELACORILANT AND P-GLYCOPROTEIN SUBSTRATES"

GENEVA, Dec. 31 -- CORCEPT THERAPEUTICS INCORPORATED (101 Redwood Shores ParkwayRedwood City, California 94065) filed a patent application (PCT/US2025/034547) for "CONCOMITANT ADMINISTRATION OF SELECTIVE GLUCOCORTICOID RECEPTOR MODULATOR RELACORILANT AND P-GLYCOPROTEIN SUBSTRATES" on Jun 20, 2025. With publication no. WO/2025/265030, the details related to the patent application was published on Dec 26, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): KUNTA, Jeevan R. (c/o Corcept Therapeutics Incorporated101 Redwood Shores ParkwayRedwood City, California 94065), CUSTODIO, Joseph M. (c/o Corc...